EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Uncovering Aristolochic Acid–Driven Mutational Signatures and Novel Biomarkers inPrimary Hepatic Angiosarcoma for Targeted Therapeutic Development

Ramzan Mohammad, Jasvir Kaur, Ruhit Ashraf, Shafkat Hussain

Pan-African Journal of Health and Psychological Sciences · 2026

DOI: 10.64261/55166d57 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pan-African Journal of Health and Psychological Sciences, 2026. Verfasst von Ramzan Mohammad und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary hepatic angiosarcoma is a very rare and extremely aggressive malignancy that has hadfew therapeutic options and has been closely linked to aristolochic acid which is a strongenvironmental carcinogen commonly found in some herbal medicines. The hallmark mutationalsignature of aristolochic acid is the observed A: T↔ T: A transversion at context-specifictrinucleotide motifs, and this pattern can be used to discriminatively identify AA-induced tumorswith genome-wide analyses. This signature can act as a molecular signature that has the potentialto explain the etiology of cancers, can aid retrospective exposure assessment, as well ascontribute to early diagnosis. Coincidently, the molecular profiling has highlighted newbiomarkers, serine/threonine kinase p53 pathways, aberrations of ERCC1 DNA repair enzyme,and up-regulation of endothelial cell markers. which have collectively enhanced diagnosis andstratification outcomes. These markers have been tested as potential predictive targets andprovide the basis of precision approaches that encompass PARP inhibitors that target DNA-repairdefects, targeted kinase inhibitors, and monoclonal antibodies against angiogenic pathways.Combination therapies that include the targeted with conventional chemotherapy have beenshown to be more effective. Even more, the development of innovative technologies, includingliquid biopsy, single-cell sequencing, and artificial intelligence-mediated searches in mutationalsignatures, further expand personalized medicine of Primary hepatic angiosarcoma and allow anearlier manifestation and precision intervention.

Zitieren

APA

Mohammad, R., Kaur, J., Ashraf, R., & Hussain, S. (2026). Uncovering Aristolochic Acid–Driven Mutational Signatures and Novel Biomarkers inPrimary Hepatic Angiosarcoma for Targeted Therapeutic Development. Pan-African Journal of Health and Psychological Sciences. https://doi.org/10.64261/55166d57

Vancouver

Mohammad R, Kaur J, Ashraf R, Hussain S. Uncovering Aristolochic Acid–Driven Mutational Signatures and Novel Biomarkers inPrimary Hepatic Angiosarcoma for Targeted Therapeutic Development. Pan-African Journal of Health and Psychological Sciences. 2026. doi:10.64261/55166d57

BibTeX
@article{Mohammad2026,
  author = {Mohammad, Ramzan and Kaur, Jasvir and Ashraf, Ruhit and Hussain, Shafkat},
  title = {Uncovering Aristolochic Acid–Driven Mutational Signatures and Novel Biomarkers inPrimary Hepatic Angiosarcoma for Targeted Therapeutic Development},
  journal = {Pan-African Journal of Health and Psychological Sciences},
  year = {2026},
  doi = {10.64261/55166d57}
}
Kostenlos starten →